Wulandari Nora, Maifitrianti Maifitrianti, Hasanah Faridlatul, Atika Sri, Dini Putri Risa
Faculty of Pharmacy and Science, University of Muhammadiyah Prof. DR. HAMKA Jl Delima II/IV Islamic Center, Malakasari, Duren Sawit, East Jakarta, Indonesia.
J Pharm Bioallied Sci. 2020 Nov;12(Suppl 2):S758-S762. doi: 10.4103/jpbs.JPBS_257_19. Epub 2020 Nov 5.
Type 2 diabetes mellitus (T2DM) is a chronic disease where most of the patients usually need polytherapy. This could affect their medication adherence (MA). However, other complex factors may also associate with MA, which are important to identify.
The purpose of this study was to evaluate the MA of patients with T2DM who received polytherapy and to identify other factors that can affect the MA.
This was a cross-sectional study conducted in seven community health centers in Jakarta with HbA representing their MA level. Poor controlled blood glucose with Hemoglobin A (HbA) of ≥7% is indicated to have low MA. All characteristics were collected to identify factors that are potentially associated with low MA. The univariate analysis tests were used to analyze factors that potentially associate with low MA. Multiple logistic regression analysis was performed in the factors to find their relationship with low MA.
The study obtained 143 patients with a female dominance (67.8%) and mean ± standard deviation (SD) age of 59.53 ± 9.251 years. Approximately 75.5% of the patients had low MA (HbA ≥ 7). Univariate analysis found that duration of T2DM significantly ( = 0.047) related to MA, where patients with T2DM of less than or equal to 5 years tended to have low MA. Logistic regression showed that patients with T2DM less than or equal to 5 years ( = 0.015, odds ratio = 1.206, 95% confidence interval = 1.216-8.014) were associated with low MA.
Patients with the duration of T2DM less than or equal to 5 years surprisingly were susceptible to have low MA. Low MA was not affected by polytherapy.
2型糖尿病(T2DM)是一种慢性病,大多数患者通常需要联合治疗。这可能会影响他们的药物依从性(MA)。然而,其他复杂因素也可能与药物依从性相关,识别这些因素很重要。
本研究的目的是评估接受联合治疗的T2DM患者的药物依从性,并识别其他可能影响药物依从性的因素。
这是一项在雅加达七个社区卫生中心进行的横断面研究,以糖化血红蛋白(HbA)代表其药物依从性水平。糖化血红蛋白(HbA)≥7%表明血糖控制不佳,药物依从性低。收集所有特征以识别可能与低药物依从性相关的因素。单因素分析测试用于分析可能与低药物依从性相关的因素。对这些因素进行多因素逻辑回归分析,以找出它们与低药物依从性的关系。
该研究共纳入143例患者,其中女性占主导(67.8%),平均年龄±标准差(SD)为59.53±9.251岁。约75.5%的患者药物依从性低(HbA≥7)。单因素分析发现,T2DM病程与药物依从性显著相关(P = 0.047),T2DM病程小于或等于5年的患者往往药物依从性低。逻辑回归显示,T2DM病程小于或等于5年的患者(P = 0.015,比值比 = 1.206,95%置信区间 = 1.216 - 8.014)与低药物依从性相关。
令人惊讶的是,T2DM病程小于或等于5年的患者易出现低药物依从性。联合治疗并不影响低药物依从性。